Individualize Antidepressant Choice
February 2023
You’ll see more focus on individualizing first-line antidepressants in adults...given the plethora of options.
About 5% of Canadian adults are affected by major depressive disorder per year.
Consider individual patient factors when narrowing down between SSRIs, SNRIs, bupropion, etc...since they’re similar in efficacy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive